Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders

Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders

The gold standard for treating high-risk non-muscle-invasive bladder cancer involves the transurethral removal of cancerous tissue followed by BCG immunotherapy. So far, there is no reliable biomarker for predicting BCG efficacy and identifying patients who will or will not respond to BCG treatment....

Full description

Saved in:
Bibliographic Details
Main Authors: Toni Boban, Blanka Milić Roje, Dora Knezović, Ana Jerončić, Hrvoje Šošić, Marijan Šitum, Janoš Terzić
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
urinary microbiome
non-muscle invasive bladder cancer
BCG
response to therapy
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1479795/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items